These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Microglial Inflammatory-Metabolic Pathways and Their Potential Therapeutic Implication in Major Depressive Disorder. Rahimian R; Belliveau C; Chen R; Mechawar N Front Psychiatry; 2022; 13():871997. PubMed ID: 35782423 [TBL] [Abstract][Full Text] [Related]
3. Serotonin in behavioral disorders. Proceedings of a symposium. November 21, 1987, Zurich, Switzerland. J Clin Psychiatry; 1988 Aug; 49 Suppl():1-73. PubMed ID: 3410838 [No Abstract] [Full Text] [Related]
4. Fluoxetine, fluvoxamine and extrapyramidal tract disorders. Baldwin D; Fineberg N; Montgomery S Int Clin Psychopharmacol; 1991; 6(1):51-8. PubMed ID: 1906498 [No Abstract] [Full Text] [Related]
5. [Therapeutic gap when it comes to behavioral symptoms and psychoses among the elderly]. Nygaard HA Tidsskr Nor Laegeforen; 2004 Oct; 124(19):2515. PubMed ID: 15477898 [No Abstract] [Full Text] [Related]
7. The breadth of action of the 5-HT3 receptor antagonists. Costall B Int Clin Psychopharmacol; 1993 Nov; 8 Suppl 2():3-9. PubMed ID: 8201244 [TBL] [Abstract][Full Text] [Related]